Literature DB >> 22867783

Whose values in health? An empirical comparison of the application of adolescent and adult values for the CHU-9D and AQOL-6D in the Australian adolescent general population.

Julie Ratcliffe1, Katherine Stevens, Terry Flynn, John Brazier, Michael G Sawyer.   

Abstract

OBJECTIVES: The Child Health Utility-9D (CHU-9D) and the Assessment of Quality of Life-6D (AQOL-6D) presently represent the only two generic preference-based instruments developed for application with young people with both adult- and adolescent-specific scoring algorithms. The main objective of this study was to compare and contrast the application of adult and adolescent scoring algorithms for the CHU-9D and AQOL-6D in valuing the health of a community-based sample of adolescents.
METHODS: A Web-based survey including the CHU-9D and the AQOL-6D was developed for administration to adolescents, aged 11 to 17 years, residing in Australia (n = 500). Individual responses to both instruments were converted to values by using first the adult and second the adolescent scoring algorithms pertaining to each instrument.
RESULTS: Both the AQOL-6D and the CHU-9D discriminated well according to health status and the presence of long-standing illness regardless of the scoring algorithm. Within each instrument, however, important discrepancies were found in that employment of the adolescent algorithm was found to result in consistently lower mean health state values for the CHU-9D but consistently higher mean health state values for the AQOL-6D relative to the employment of their respective adult algorithms and these differences were statistically significant (P < 0.05).
CONCLUSION: The differences in adolescent and adult values for identical health states are more profound for the CHU-9D and ultimately may be significant enough to have an impact on health care policy. It is important to note that there are important differences between the CHU-9D instrument and the AQOL-6D instrument that may also have a significant impact on the valuations obtained.
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22867783     DOI: 10.1016/j.jval.2012.04.005

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  22 in total

1.  Measuring Health-Related Quality of Life in Adolescent Populations: An Empirical Comparison of the CHU9D and the PedsQLTM 4.0 Short Form 15.

Authors:  Karin Dam Petersen; Gang Chen; Christine Mpundu-Kaambwa; Katherine Stevens; John Brazier; Julie Ratcliffe
Journal:  Patient       Date:  2018-02       Impact factor: 3.883

2.  A review of preference-based measures for the assessment of quality of life in children and adolescents with cerebral palsy.

Authors:  Christine Mpundu-Kaambwa; Gang Chen; Elisabeth Huynh; Remo Russo; Julie Ratcliffe
Journal:  Qual Life Res       Date:  2018-03-22       Impact factor: 4.147

3.  Does one size fit all? Assessing the preferences of older and younger people for attributes of quality of life.

Authors:  Julie Ratcliffe; Emily Lancsar; Thomas Flint; Billingsley Kaambwa; Ruth Walker; Gill Lewin; Mary Luszcz; Ian D Cameron
Journal:  Qual Life Res       Date:  2016-08-23       Impact factor: 4.147

Review 4.  A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations.

Authors:  Gang Chen; Julie Ratcliffe
Journal:  Pharmacoeconomics       Date:  2015-10       Impact factor: 4.981

5.  Economic Evaluations of Childhood Hearing Loss Screening Programmes: A Systematic Review and Critique.

Authors:  Rajan Sharma; Yuanyuan Gu; Teresa Y C Ching; Vivienne Marnane; Bonny Parkinson
Journal:  Appl Health Econ Health Policy       Date:  2019-06       Impact factor: 2.561

6.  Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best-Worst Scaling.

Authors:  Kim Dalziel; Max Catchpool; Borja García-Lorenzo; Inigo Gorostiza; Richard Norman; Oliver Rivero-Arias
Journal:  Pharmacoeconomics       Date:  2020-05       Impact factor: 4.981

7.  Mapping scores from the Strengths and Difficulties Questionnaire (SDQ) to preference-based utility values.

Authors:  Gareth Furber; Leonie Segal; Matthew Leach; Jane Cocks
Journal:  Qual Life Res       Date:  2013-08-13       Impact factor: 4.147

8.  Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT.

Authors:  Jonathan M Batchelor; Kim S Thomas; Perways Akram; Jaskiran Azad; Anthony Bewley; Joanne R Chalmers; Seau Tak Cheung; Lelia Duley; Viktoria Eleftheriadou; Robert Ellis; Adam Ferguson; Jonathan Mr Goulding; Rachel H Haines; Hamdi Hamad; John R Ingram; Bisola Laguda; Paul Leighton; Nick Levell; Areti Makrygeorgou; Garry D Meakin; Adam Millington; Malobi Ogboli; Amirtha Rajasekaran; Jane C Ravenscroft; Andrew Rogers; Tracey H Sach; Miriam Santer; Julia Stainforth; Wei Tan; Shyamal Wahie; Jennifer White; Maxine E Whitton; Hywel C Williams; Andrew Wright; Alan A Montgomery
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

9.  Australian adolescent population norms for the child health utility index 9D-results from the young minds matter survey.

Authors:  Long Khanh-Dao Le; Scott Richards-Jones; Mary Lou Chatterton; Lidia Engel; David Lawrence; Chris Stevenson; Genevieve Pepin; Julie Ratcliffe; Michael Sawyer; Cathrine Mihalopoulos
Journal:  Qual Life Res       Date:  2021-05-17       Impact factor: 4.147

10.  An Assessment of the Validity and Reliability of the Pediatric Child Health Utility 9D in Children with Inflammatory Bowel Disease.

Authors:  Naazish S Bashir; Thomas D Walters; Anne M Griffiths; Wendy J Ungar
Journal:  Children (Basel)       Date:  2021-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.